Axogen Statistics
NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
36.04-0.27 (-0.74%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Axogen by the numbers
Axogen has a market capitalization of $2.11 billion based on 58.67M shares outstanding. With trailing EPS of $-0.66, Axogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.0% below its 50-day average and 7.6% below its 200-day average.
Average daily trading volume is 1.22M shares, or about $44.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AXGN valuation vs. peer median
| Metric | AXGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.11B | $101.63M | +1981% |
| Avg. volume | 1.22M | 458.84K | +167% |
Peer median across 8 companies: TMDX, VANI, STXS, HYPR, LIVN, ECOR, NRXS, OM.
Valuation
- Market cap
- $2.11B
- Forward P/E
- 52.38
- EPS (TTM)
- $-0.66
- Shares outstanding
- 58.67M
Price and trading
- Previous close
- 36.31
- Open
- 36.31
- Day range
- 35.83 – 36.88
- 52-week range
- 15.27 – 52.91
- 52-week change
- +113.25%
- Beta
- —
- Volume
- 1.60M
- Average volume
- 1.22M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.11B
- Forward Pe
- 52.38
- Eps
- -0.66
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 52.91
- Week52 Low
- 15.27
- Avg Volume
- 1.22M
- Shares Outstanding
- 58.67M
- Ma50
- 45.62
- Ma200
- 39.01
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -31.88%
- Pct From52w Low
- 136.02%